Medesis Pharma SA
PAR:ALMDP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medesis Pharma SA
PAR:ALMDP
|
FR |
|
SPC Nickel Corp
XTSX:SPC
|
CA |
|
Tokyo Ichiban Foods Co Ltd
TSE:3067
|
JP |
|
iRhythm Technologies Inc
NASDAQ:IRTC
|
US |
|
B
|
Beijing Enterprises Environment Group Ltd
HKEX:154
|
HK |
|
Top Education Group Ltd
HKEX:1752
|
AU |
|
Juki Corp
TSE:6440
|
JP |
|
I
|
Isu Specialty Chemical Co Ltd
KRX:457190
|
KR |
|
Macbee Planet Inc
TSE:7095
|
JP |
|
Phoenix Global Resources PLC
LSE:PGR
|
UK |
|
Cesar SA
PAR:ALCES
|
FR |
|
P
|
Petsec Energy Ltd
ASX:PSA
|
AU |
|
Riken Vitamin Co Ltd
TSE:4526
|
JP |
|
Synovus Financial Corp
NYSE:SNV
|
US |
|
L
|
L&P Global Bhd
KLSE:L&PBHD
|
MY |
|
Singaraja Putra Tbk PT
IDX:SINI
|
ID |
Bankruptcy Probability
Medesis Pharma SA's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Medesis Pharma SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Medesis Pharma SA
PAR:ALMDP
|
1.8m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
266.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
98.8B ZAR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Schlumberger NV
NYSE:SLB
|
77B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
66.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
60.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
58.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
G
|
Galderma Group AG
SIX:GALD
|
37.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Symbotic Inc
NASDAQ:SYM
|
34.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Medesis Pharma SA's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Medesis Pharma SA has total debt of 1.3m EUR. This includes both short-term (0 EUR) and long-term (1.3m EUR) debt.
You can find a full breakdown on its Balance Sheet.
